The verified answer
As of Sep 2026, DEPLOY verifies Dräger: 1 model, 2 active incidents. 1 source back the record.
Models
1
Employees
17k
Overview
Dräger is a publicly listed German medical and safety technology company headquartered in Lübeck, Germany, founded in 1889 by J. Heinrich Dräger. The family-run company develops, manufactures, and sells devices and systems in the fields of medical and safety technology — including ventilators, anaesthetic machines, gas detectors, SCBA, and breathalyzers — sold in over 190 countries. The company is listed on the Frankfurt Stock Exchange (FWB: DRW3) and generated approximately €3.37 billion in revenue in 2024 with over 16,500 employees.
Verified record
- Verified deployments
- None on file
- Active incidents
- 2 incidents on file
Key facts
HQ
Focus
Technology
Backerssee investors →
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Dräger on the deployment map
View the global mapDräger has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Dräger on the DEPLOY record yet. Track Dräger to know the moment the first one is verified.
Current leadership (1)
- Stefan Dräger Chairman of the Executive Boardsecondary-verified
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Dräger (2)
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Recent coverage
Dräger in third-party press
Financial state
- Employees
- 16,598
- Reporting basis
- private_reported
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 8, 2026
Added to the verified registry
- Incident recordedMay 1, 2022
FDA Class I recall of 35,950 SafeStar 55 breathing system filters over possible oxygen...
- Incident recordedJan 7, 2016
FDA Class I recall of Dräger Oxylog emergency transport ventilators over ventilation halt...
Sources (1)
Common questions
What is Dräger?
What does Dräger make?
Who is the CEO of Dräger?
Where does Dräger operate robots?
Is Dräger a top robotics company?
When was Dräger founded?
Are there any incidents involving Dräger?
Is Dräger safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-05
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Dräger.In the press
Recent coverage mentioning Dräger from third-party publications. Automatically surfaced; not part of the verified registry record.
VIKING Appointed Official Sales, Service Partner for Dräger Marine Safety Equipment
VIKING has been appointed as Official Preferred Global Sales and Service Partner for the full range of respiratory protection equipment and mobile gas detection equipment offered…
Dräger PSS AirBoss SCBA Now Available for Purchase in North America
Dräger launched the PSS AirBoss SCBA, certified to NFPA 1970:2025, delivering next-generation breathing protection for firefighters in North America.
FDA adds Class I tag to Dräger's recall of 36K ventilator filters
FDA designated Dräger's recall of 35,950 SafeStar 55 breathing system filters as Class I due to possible obstruction that could block oxygen flow to patients.
Dräger Medical Recalls Fabius Anesthesia Machines Due to Production Step Error - Medical Product Outsourcing
<a…
FDA: Dräger Med transport ventilator recall is Class I
FDA issued a Class I recall for Dräger Oxylog 2000 plus and Oxylog 3000 ventilators over an electrical issue that could halt ventilation therapy.
Machine-readable surfaces
- Markdown mirror: /companies/drager.md
- RSS feed: /companies/drager/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/552c2bf6-4bb2-4a53-992d-ff157ce2e122
- Revision history: /companies/drager/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Heat Index
Serious50/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Dräger draws attention at the 23rd percentile but verifies reality at the insufficient-data level among other robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 12, 2026